RE:U.S. lawmakers to investigate approval, pricing of Alzheimer Here's what I took away from that article... holy smokes... if true, biib still undervalued... I've been using $25B for the global market, so $57B just for the medicare market is insanity
"At $56,000 a year, the Kaiser Family Foundation estimates that Medicare could spend $57 billion or more per year on Aduhelm, which is more than Medicare Part B spends on all other drugs combined, the House Committee said."